OrganoPlate Platform is MIMETAS's high-throughput organ-on-a-chip system for 3D human tissue models.
The OrganoPlate is a plate-based organ-on-a-chip system that grows 3D perfused human tissue models in a standard microplate format, enabling high-throughput assays without external pumps. Pharmaceutical researchers use it for efficacy, ADME and toxicity studies across organ models including liver, gut, kidney, lung and blood-brain barrier.
The platform supports MIMETAS's OrganoReady ready-to-use models and OrganoAccess services, used by drug discovery teams to generate human-relevant data that reduces reliance on animal testing in preclinical development.
| Attribute | OrganoPlate Platform | ParVivo Platform | |
|---|---|---|---|
| Provider |  |  | |
| Founded | 2013 | 2007 | |
| Sells To | Pharmaceutical Manufacturers | Enterprise | |
| Pricing Model | Product Sales, Service Fees | Recurring | |
| Ownership | Private | Venture-backed |
Provider
Founded 2013
Sells To Pharmaceutical Manufacturers
Pricing Model Product Sales, Service Fees
Ownership Private
Provider
Founded 2007
Sells To Enterprise
Pricing Model Recurring
Ownership Venture-backed
Emulate Organ-Chip Platform is an organ-on-a-chip system for human-relevant preclinical drug testing.
Emulate Organ-Chip Platform is an organ-on-a-chip system for human-relevant preclinical drug testing.
PhysioMimix is CN Bio's organ-on-a-chip microphysiological system for preclinical drug discovery.
PhysioMimix is CN Bio's organ-on-a-chip microphysiological system for preclinical drug discovery.
Patient-Derived Organoid Platform is the primary commercial offering marketed by Xilis to its core customer segments.
High-throughput Organ-Chip instrument capable of running 96 Organ-Chip samples per run.
Patient-Derived Organoid Platform is the primary commercial offering marketed by Xilis to its core customer segments.
High-throughput Organ-Chip instrument capable of running 96 Organ-Chip samples per run.